Serenity Age
Concern
Across Fitzpatrick III–V skin tones — the majority of darker skin tones — the most common consultation is the same: the patch on the cheekbone that did not fade. Melasma, post-inflammatory hyperpigmentation, the marks that follow acne and friction. The pattern is photoresponsive, the mechanism is mapped, and visible improvement is reachable with consistent care. The Whitepurity range is built for that work — Alpha-Arbutin for stable tyrosinase inhibition, Niacinamide-led brightening, and the SPF discipline that decides whether any of the rest will hold.
Last reviewed by BIOSAR Scientific Team, PharmD, Cosmetic Chemistry, Pharmacy practice on .
Epidemiology
Hyperpigmentation disorders disproportionately affect skin of color. Post-inflammatory hyperpigmentation (PIH) develops in approximately 65% of acne sufferers with Fitzpatrick III–V skin tones (Source: Davis & Callender, J Clin Aesthet Dermatol 2010). Melasma — the chronic, often symmetrical facial pigmentation associated with hormonal triggers — affects 15–30% of adult women, most often those with Fitzpatrick III–V skin tones (Source: Ortonne et al., JEADV 2009; Handel et al., An Bras Dermatol 2014). UV exposure is the dominant driver: more than 90% of melasma patients report flares with sun exposure, and pregnancy, oral contraceptives, and hormone replacement each amplify the response. PIH after acne is the dominant pigmentation variant in adolescents with deeper skin tones.
Why it happens
UV radiation activates tyrosinase and accelerates melanin synthesis. Visible light, particularly the blue-violet band, drives melasma even when UV is blocked. Daily broad-spectrum SPF with iron oxide is the foundation of every pigmentation routine — without it, no other active will deliver visible results.
Acne, eczema, friction, and cosmetic procedures release inflammatory cytokines that activate melanocytes in the lesion bed. The result is a brown or violet mark that persists for three to twelve months after the original lesion resolves. Treating active inflammation is prerequisite to fading PIH.
Pregnancy, oral contraceptives, and hormone replacement each elevate oestrogen and progesterone, which upregulate melanocyte proliferation and tyrosinase activity. Melasma flares strongly with hormonal change and rarely fades fully without addressing both pigment and the hormonal driver.
Fitzpatrick III–V skin tones produce larger, more numerous melanosomes than lighter tones, so the same inflammatory or UV trigger yields a deeper mark. Family history of melasma is the strongest predictor of personal melasma risk, especially in deeper skin tones.
Mechanism
Hyperpigmentation is rarely a single disorder. The visible mark — whether brown, grey, or violet — is the endpoint of a tightly regulated melanocyte response that runs through tyrosinase, melanosome transfer, and dermal pigment trapping. Effective treatment requires understanding which step in the cascade produces the specific lesion, because each step has its own active ingredients.
Melanocytes sit at the basal layer of the epidermis. Each cell extends dendrites to roughly thirty neighbouring keratinocytes, packaging melanin into membrane-bound organelles called melanosomes and transferring them through phagocytic uptake. The rate-limiting enzyme in melanogenesis is tyrosinase, which converts L-tyrosine to L-DOPA and then to dopaquinone — the chemical entry point of the entire pigment pathway.
Almost every effective topical pigmentation active inhibits tyrosinase or interrupts melanosome transfer. Vitamin C reduces dopaquinone back to L-DOPA. Alpha-arbutin and kojic acid bind the active site of tyrosinase. Niacinamide does not touch tyrosinase but blocks the transfer of finished melanosomes from melanocyte to keratinocyte — a mechanism that makes it complementary to tyrosinase inhibitors rather than redundant. The clinical pattern is consistent: layered actives outperform any single agent in controlled trials.
PIH is the pigment that follows inflammation — acne, eczema, ingrown hair, cosmetic procedures, or thermal injury. The inflammatory cytokine cascade (IL-1, prostaglandins, leukotrienes) directly activates melanocytes in the lesion bed. The result is a sharply demarcated brown or violet mark that can persist three to twelve months after the original insult resolves.
Two factors lengthen PIH duration in deeper skin tones. First, Fitzpatrick III–V melanocytes produce larger, more numerous melanosomes — the same inflammatory signal yields a deeper mark. Second, ongoing UV exposure renews tyrosinase activation each day, so the mark fades only as fast as fresh pigment production drops below the natural turnover rate. Daily SPF and a tyrosinase inhibitor in the morning, paired with a niacinamide-rich serum at night, is the standard published protocol.
Melasma presents as symmetric brown or grey-brown patches across the cheeks, forehead, upper lip, and chin. It is strongly hormone-driven. Pregnancy, oral contraceptives, and hormone replacement each elevate oestrogen and progesterone, which upregulate melanocyte proliferation and tyrosinase activity. Genetic susceptibility runs strong in deeper skin tones.
Melasma is more difficult to clear than PIH. The pigment often deposits not only in the epidermis but also in dermal macrophages, where topical actives reach poorly. Tranexamic acid — both topical and low-dose oral, where prescribed — is the most studied modern intervention, with multiple controlled trials showing significant fade over three months (Source: Taraz et al., Dermatol Ther 2017). Vitamin C, alpha-arbutin, and azelaic acid are first-line topical complements. Crucially, melasma always rebounds without rigorous daily SPF, including a tinted mineral filter that blocks visible light — visible light alone provokes melasma in pigmented skin, even with strong UV protection.
Across all three pigmentation types, UV exposure is the single largest accelerant. UVA renews tyrosinase activation daily. UVB triggers immediate pigment darkening. Visible light, particularly the blue-violet 400–450 nm band, drives melasma even when UV is fully blocked. Mineral filters with iron oxides cover this gap and remain the preferred photoprotection for pigmentation patients. A pigmentation routine without daily broad-spectrum SPF is a routine that will fail. The clinical evidence on this point is unambiguous and decades old.
Pharmacist's note
Pigmentation work is futile without daily broad-spectrum SPF. We see patients who have invested in vitamin C, niacinamide, and tranexamic acid for months without progress — almost every case traces back to a missed morning SPF step. The active ingredients work. The protocol around them needs to work too.
From the BIOSAR ranges
The science
Hyperpigmentation begins when UV, inflammation, and hormones over-activate tyrosinase and drive excess melanin upward. The Whitepurity routine answers on every front: Alpha-Arbutin curbs tyrosinase, Niacinamide slows pigment transfer, Vitamin C evens tone, and Tranexamic Acid targets stubborn melasma, all held by daily SPF50+.
Related conditions
Pigmentation sits at different depths in the skin. Surface discoloration responds within weeks. Deeper melasma and post-inflammatory marks often require three to six months of consistent care plus daily SPF.
Yes. UV exposure actively reignites melanocyte activity. Without daily broad-spectrum SPF50+, any brightening routine is working against the sun — and losing.
Where to look next
Aggressive scrubbing, chemical peels above tolerated strength, laser without melanocyte-aware settings, and ongoing friction all trigger PIH. The pattern often mirrors the trauma — perfectly geometric marks after waxing, linear marks along glasses or mask edges, diffuse marks after harsh peels.
Most pigmentation treatment failures trace back to inconsistent SPF. UVA penetrates clouds and glass; incidental indoor and in-car exposure is enough to renew melanin synthesis daily. Effective protocols require SPF 30+ every morning, reapplication every two hours outdoors, and a tinted mineral filter for active melasma patients.
Each works on a different mechanism. Using them together in one routine (layered by time of day or in one multi-pathway serum) is more effective than any single active alone.
Alpha-Arbutin, Niacinamide, Vitamin C, Azelaic Acid, and low-concentration topical Salicylic Acid (≤2%, limited areas) are generally considered pregnancy-friendly. Avoid Retinol. Check with your doctor for your specific situation.
